Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Gennaio 2024 - 1:00PM
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a
clinical-stage biopharmaceutical company redefining neuroscience
drug development, today announced that the Company will present at
the 42nd Annual J.P. Morgan Healthcare Conference being held in San
Francisco, CA on Monday, January 8, 2024 at 11:15 a.m. PT (2:15
p.m. ET).
A live webcast of the presentation will be
available on the Events and Presentations section of the Company’s
website at www.neumoratx.com. A replay of the webcast will be
available following the completion of the event and will be
archived for up to 30 days.
About NeumoraNeumora Therapeutics,
Inc. is a clinical-stage biopharmaceutical company founded to
confront the global brain disease crisis by taking a fundamentally
different approach to the way treatments for brain diseases are
developed. Our therapeutic pipeline currently consists of seven
clinical and preclinical neuroscience programs that target novel
mechanisms of action for a broad range of underserved
neuropsychiatric disorders and neurodegenerative diseases. Our work
is supported by an integrated suite of translational, clinical, and
computational tools to generate insights that can enable precision
medicine approaches. Neumora’s mission is to redefine neuroscience
drug development by bringing forward the next generation of novel
therapies that offer improved treatment outcomes and quality of
life for patients suffering from brain diseases.
Neumora Contact:Helen
Rubinstein315-382-3979Helen.Rubinstein@neumoratx.com
Grafico Azioni Neumora Therapeutics (NASDAQ:NMRA)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Neumora Therapeutics (NASDAQ:NMRA)
Storico
Da Mag 2023 a Mag 2024